(Reuters) -The U.S. Food and Drug Administration is probing the death of a patient who developed harmful antibodies after taking Takeda Pharmaceuticals' blood disorder therapy, the health regulator said on Friday.
The pediatric patient died about 10 months after starting Takeda's drug Adzynma as a preventive therapy, the agency said.
The child had congenital thrombotic thrombocytopenic purpura (cTTP), an inherited condition that causes blood clots in small vessels and can lead to organ damage.
The FDA said the child developed antibodies that blocked the activity of ADAMTS13, an enzyme critical for blood clotting.
Takeda did not immediately respond to Reuters request for comment.
Adzynma, approved in 2023 as the first therapy for cTTP, replaces the ADAMTS13 protein to help prevent dangerous blood clots.
The agency added it has received multiple postmarketing reports of patients developing neutralizing antibodies to ADAMTS13 after treatment with Adzynma.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Smuggler who called migrants 'chickens' jailed - 2Become the best at Discussion: 6 Procedures for Progress
- 3Greenland’s melting ice and landslide-prone fjords make the oil and minerals Trump is eyeing dangerous to extract
- 4Car Investigation: A Survey of \Past the Outside\ Car
- 5Soldiers seize power in Guinea-Bissau and detain the president
- Carnival fever hits Lagos as locals celebrate Afro-Brazilian heritage
- How a rare drug made from scientists' blood saves babies from botulism
- Mosquitoes carrying malaria are evolving more quickly than insecticides can kill them – researchers pinpoint how
- Which Countries Would Suffer Most in a Global Energy Shutdown? This Study Has Answers
- Figure out How to Acquire Rewarding Open Record Rewards
- Vaccine makers raise concerns over US panel's shift away from hepatitis B shots for newborns
- Pulsars to the extreme: Spinning dead stars found blasting radio signals from the 'edge of their magnetic reach'
- Israel Police decry online defamation campaign against female officer in Jerusalem
- NASA set to launch Artemis 2 moon mission today, the 1st crewed lunar flight since 1972
